nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CXCL8—EBV LMP1 signaling—PDLIM7—pharynx cancer	0.0609	0.109	CbGpPWpGaD
Diclofenac—PLA2G2A—tongue—pharynx cancer	0.0322	0.073	CbGeAlD
Diclofenac—ASIC1—saliva-secreting gland—pharynx cancer	0.024	0.0544	CbGeAlD
Diclofenac—PLA2G2A—mouth—pharynx cancer	0.0217	0.0491	CbGeAlD
Diclofenac—CYP2E1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0184	0.0329	CbGpPWpGaD
Diclofenac—CYP1A1—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0173	0.031	CbGpPWpGaD
Diclofenac—KCNQ2—brainstem—pharynx cancer	0.0172	0.039	CbGeAlD
Diclofenac—CYP2E1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0161	0.0288	CbGpPWpGaD
Diclofenac—CXCR1—lymph node—pharynx cancer	0.0153	0.0346	CbGeAlD
Diclofenac—CYP1A1—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0152	0.0272	CbGpPWpGaD
Diclofenac—ASIC1—spinal cord—pharynx cancer	0.0146	0.0331	CbGeAlD
Diclofenac—PLA2G2A—saliva-secreting gland—pharynx cancer	0.0144	0.0328	CbGeAlD
Diclofenac—TTR—neck—pharynx cancer	0.014	0.0317	CbGeAlD
Diclofenac—ASIC1—head—pharynx cancer	0.013	0.0294	CbGeAlD
Diclofenac—PLA2G2A—epithelium—pharynx cancer	0.0126	0.0286	CbGeAlD
Diclofenac—PLA2G2A—trachea—pharynx cancer	0.0111	0.0253	CbGeAlD
Diclofenac—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0111	0.0198	CbGpPWpGaD
Diclofenac—CXCL8—trachea—pharynx cancer	0.011	0.025	CbGeAlD
Diclofenac—CYP2C18—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0107	0.0192	CbGpPWpGaD
Diclofenac—TTR—brainstem—pharynx cancer	0.0107	0.0242	CbGeAlD
Diclofenac—UGT2B7—Phase II conjugation—CNDP2—pharynx cancer	0.0105	0.0188	CbGpPWpGaD
Diclofenac—KCNQ3—head—pharynx cancer	0.0103	0.0234	CbGeAlD
Diclofenac—PLA2G2A—lymphoid tissue—pharynx cancer	0.0097	0.022	CbGeAlD
Diclofenac—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00969	0.0173	CbGpPWpGaD
Diclofenac—KCNQ2—head—pharynx cancer	0.00949	0.0215	CbGeAlD
Diclofenac—CYP2C18—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00943	0.0169	CbGpPWpGaD
Diclofenac—ASIC1—lymph node—pharynx cancer	0.00908	0.0206	CbGeAlD
Diclofenac—CXCL8—spinal cord—pharynx cancer	0.00871	0.0198	CbGeAlD
Diclofenac—UGT1A1—Phase II conjugation—CNDP2—pharynx cancer	0.00853	0.0153	CbGpPWpGaD
Diclofenac—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00853	0.0152	CbGpPWpGaD
Diclofenac—PLA2G2A—head—pharynx cancer	0.00782	0.0177	CbGeAlD
Diclofenac—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00748	0.0134	CbGpPWpGaD
Diclofenac—SLCO1C1—spinal cord—pharynx cancer	0.00743	0.0169	CbGeAlD
Diclofenac—TTR—lymphoid tissue—pharynx cancer	0.00732	0.0166	CbGeAlD
Diclofenac—PTGS1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00693	0.0124	CbGpPWpGaD
Diclofenac—CYP1A1—mouth—pharynx cancer	0.00677	0.0154	CbGeAlD
Diclofenac—CXCL8—Bladder Cancer—CDH1—pharynx cancer	0.00672	0.012	CbGpPWpGaD
Diclofenac—TTR—spinal cord—pharynx cancer	0.00664	0.0151	CbGeAlD
Diclofenac—ALOX5—lymphoid tissue—pharynx cancer	0.00664	0.0151	CbGeAlD
Diclofenac—SLCO1C1—head—pharynx cancer	0.0066	0.015	CbGeAlD
Diclofenac—UGT2B7—NRF2 pathway—ADH7—pharynx cancer	0.00633	0.0113	CbGpPWpGaD
Diclofenac—CYP2C18—Biological oxidations—CNDP2—pharynx cancer	0.00631	0.0113	CbGpPWpGaD
Diclofenac—UGT2B7—Biological oxidations—CNDP2—pharynx cancer	0.00614	0.011	CbGpPWpGaD
Diclofenac—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00607	0.0109	CbGpPWpGaD
Diclofenac—SCN4A—head—pharynx cancer	0.00607	0.0138	CbGeAlD
Diclofenac—ABCC1—parotid gland—pharynx cancer	0.006	0.0136	CbGeAlD
Diclofenac—ABCC4—NRF2 pathway—ADH7—pharynx cancer	0.00595	0.0106	CbGpPWpGaD
Diclofenac—TTR—head—pharynx cancer	0.0059	0.0134	CbGeAlD
Diclofenac—TTR—Extracellular matrix organization—MMP8—pharynx cancer	0.00575	0.0103	CbGpPWpGaD
Diclofenac—CYP2C18—Biological oxidations—ADH7—pharynx cancer	0.00571	0.0102	CbGpPWpGaD
Diclofenac—PTGS2—mouth—pharynx cancer	0.00568	0.0129	CbGeAlD
Diclofenac—UGT2B7—Biological oxidations—ADH7—pharynx cancer	0.00555	0.00993	CbGpPWpGaD
Diclofenac—PLA2G2A—lymph node—pharynx cancer	0.00547	0.0124	CbGeAlD
Diclofenac—CXCL8—lymph node—pharynx cancer	0.00542	0.0123	CbGeAlD
Diclofenac—CXCL8—Syndecan-3-mediated signaling events—EGFR—pharynx cancer	0.00536	0.00959	CbGpPWpGaD
Diclofenac—ALOX5—head—pharynx cancer	0.00535	0.0121	CbGeAlD
Diclofenac—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00528	0.00945	CbGpPWpGaD
Diclofenac—CYP2E1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00518	0.00925	CbGpPWpGaD
Diclofenac—UGT1A1—NRF2 pathway—ADH7—pharynx cancer	0.00515	0.0092	CbGpPWpGaD
Diclofenac—CXCL8—Bladder Cancer—CCND1—pharynx cancer	0.00501	0.00895	CbGpPWpGaD
Diclofenac—CYP2C18—Biological oxidations—ADH1B—pharynx cancer	0.00501	0.00895	CbGpPWpGaD
Diclofenac—UGT1A1—Biological oxidations—CNDP2—pharynx cancer	0.00499	0.00892	CbGpPWpGaD
Diclofenac—CYP1A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00488	0.00873	CbGpPWpGaD
Diclofenac—UGT2B7—Biological oxidations—ADH1B—pharynx cancer	0.00487	0.00871	CbGpPWpGaD
Diclofenac—CYP1A1—parotid gland—pharynx cancer	0.00471	0.0107	CbGeAlD
Diclofenac—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00463	0.00829	CbGpPWpGaD
Diclofenac—SLCO1C1—lymph node—pharynx cancer	0.00462	0.0105	CbGeAlD
Diclofenac—CYP2E1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00454	0.00812	CbGpPWpGaD
Diclofenac—UGT1A1—Biological oxidations—ADH7—pharynx cancer	0.00451	0.00807	CbGpPWpGaD
Diclofenac—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00447	0.008	CbGpPWpGaD
Diclofenac—ABCC1—trachea—pharynx cancer	0.00443	0.0101	CbGeAlD
Diclofenac—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—pharynx cancer	0.00435	0.00777	CbGpPWpGaD
Diclofenac—CYP1A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00428	0.00765	CbGpPWpGaD
Diclofenac—PTGS1—Biological oxidations—CNDP2—pharynx cancer	0.00407	0.00727	CbGpPWpGaD
Diclofenac—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00399	0.00714	CbGpPWpGaD
Diclofenac—UGT1A1—Biological oxidations—ADH1B—pharynx cancer	0.00396	0.00708	CbGpPWpGaD
Diclofenac—CYP1A1—epithelium—pharynx cancer	0.00394	0.00893	CbGeAlD
Diclofenac—CXCL8—Bladder Cancer—EGFR—pharynx cancer	0.00393	0.00702	CbGpPWpGaD
Diclofenac—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00392	0.00701	CbGpPWpGaD
Diclofenac—ALOX5—lymph node—pharynx cancer	0.00374	0.0085	CbGeAlD
Diclofenac—PTGS1—Biological oxidations—ADH7—pharynx cancer	0.00368	0.00658	CbGpPWpGaD
Diclofenac—ABCC4—head—pharynx cancer	0.00365	0.00827	CbGeAlD
Diclofenac—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00364	0.00651	CbGpPWpGaD
Diclofenac—SLC22A8—head—pharynx cancer	0.00362	0.00821	CbGeAlD
Diclofenac—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0035	0.00626	CbGpPWpGaD
Diclofenac—CYP1A1—trachea—pharynx cancer	0.00348	0.0079	CbGeAlD
Diclofenac—PTGS1—epithelium—pharynx cancer	0.00346	0.00785	CbGeAlD
Diclofenac—PTGS2—epithelium—pharynx cancer	0.00331	0.0075	CbGeAlD
Diclofenac—CXCL8—Bladder Cancer—TP53—pharynx cancer	0.0033	0.0059	CbGpPWpGaD
Diclofenac—PTGS1—Biological oxidations—ADH1B—pharynx cancer	0.00323	0.00577	CbGpPWpGaD
Diclofenac—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00319	0.00571	CbGpPWpGaD
Diclofenac—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pharynx cancer	0.00315	0.00563	CbGpPWpGaD
Diclofenac—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00312	0.00559	CbGpPWpGaD
Diclofenac—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00311	0.00556	CbGpPWpGaD
Diclofenac—CYP2B6—Biological oxidations—CNDP2—pharynx cancer	0.0031	0.00555	CbGpPWpGaD
Diclofenac—PTGS1—trachea—pharynx cancer	0.00306	0.00694	CbGeAlD
Diclofenac—CYP2E1—Biological oxidations—CNDP2—pharynx cancer	0.00304	0.00544	CbGpPWpGaD
Diclofenac—CXCL8—ATF-2 transcription factor network—CCND1—pharynx cancer	0.00299	0.00535	CbGpPWpGaD
Diclofenac—PLA2G2A—Spinal Cord Injury—CCND1—pharynx cancer	0.00298	0.00533	CbGpPWpGaD
Diclofenac—CYP2B6—lymphoid tissue—pharynx cancer	0.00295	0.00669	CbGeAlD
Diclofenac—PTGS2—trachea—pharynx cancer	0.00292	0.00663	CbGeAlD
Diclofenac—KCNQ3—L1CAM interactions—EGFR—pharynx cancer	0.00291	0.0052	CbGpPWpGaD
Diclofenac—KCNQ2—L1CAM interactions—EGFR—pharynx cancer	0.00291	0.0052	CbGpPWpGaD
Diclofenac—CYP1A1—Biological oxidations—CNDP2—pharynx cancer	0.00287	0.00512	CbGpPWpGaD
Diclofenac—CYP2B6—Biological oxidations—ADH7—pharynx cancer	0.00281	0.00502	CbGpPWpGaD
Diclofenac—CYP2E1—lymphoid tissue—pharynx cancer	0.00277	0.00627	CbGeAlD
Diclofenac—CYP2E1—Biological oxidations—ADH7—pharynx cancer	0.00275	0.00492	CbGpPWpGaD
Diclofenac—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00273	0.00488	CbGpPWpGaD
Diclofenac—ALB—lymph node—pharynx cancer	0.00264	0.00598	CbGeAlD
Diclofenac—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.00263	0.0047	CbGpPWpGaD
Diclofenac—CXCL8—AP-1 transcription factor network—CCND1—pharynx cancer	0.00261	0.00467	CbGpPWpGaD
Diclofenac—CYP1A1—Biological oxidations—ADH7—pharynx cancer	0.00259	0.00463	CbGpPWpGaD
Diclofenac—ABCC4—lymph node—pharynx cancer	0.00255	0.00579	CbGeAlD
Diclofenac—PTGS2—lymphoid tissue—pharynx cancer	0.00255	0.00578	CbGeAlD
Diclofenac—CYP2E1—spinal cord—pharynx cancer	0.00251	0.00569	CbGeAlD
Diclofenac—CYP2B6—Biological oxidations—ADH1B—pharynx cancer	0.00246	0.0044	CbGpPWpGaD
Diclofenac—ABCC4—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00246	0.00439	CbGpPWpGaD
Diclofenac—CYP1A1—head—pharynx cancer	0.00244	0.00554	CbGeAlD
Diclofenac—PTGS1—spinal cord—pharynx cancer	0.00242	0.00548	CbGeAlD
Diclofenac—CYP2E1—Biological oxidations—ADH1B—pharynx cancer	0.00241	0.00431	CbGpPWpGaD
Diclofenac—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0024	0.00429	CbGpPWpGaD
Diclofenac—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.00238	0.00425	CbGpPWpGaD
Diclofenac—CYP2B6—head—pharynx cancer	0.00237	0.00539	CbGeAlD
Diclofenac—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.00235	0.00419	CbGpPWpGaD
Diclofenac—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pharynx cancer	0.00235	0.00419	CbGpPWpGaD
Diclofenac—PLA2G2A—Spinal Cord Injury—EGFR—pharynx cancer	0.00234	0.00418	CbGpPWpGaD
Diclofenac—PTGS2—spinal cord—pharynx cancer	0.00231	0.00524	CbGeAlD
Diclofenac—CYP1A1—Biological oxidations—ADH1B—pharynx cancer	0.00227	0.00406	CbGpPWpGaD
Diclofenac—CYP2E1—head—pharynx cancer	0.00223	0.00506	CbGeAlD
Diclofenac—SCN4A—L1CAM interactions—EGFR—pharynx cancer	0.0022	0.00394	CbGpPWpGaD
Diclofenac—CXCL8—LPA receptor mediated events—EGFR—pharynx cancer	0.0022	0.00393	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—CNDP2—pharynx cancer	0.00219	0.00391	CbGpPWpGaD
Diclofenac—ABCC1—lymph node—pharynx cancer	0.00218	0.00494	CbGeAlD
Diclofenac—PTGS1—head—pharynx cancer	0.00215	0.00487	CbGeAlD
Diclofenac—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00214	0.00382	CbGpPWpGaD
Diclofenac—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00212	0.00379	CbGpPWpGaD
Diclofenac—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00211	0.00376	CbGpPWpGaD
Diclofenac—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00208	0.00373	CbGpPWpGaD
Diclofenac—PTGS2—head—pharynx cancer	0.00205	0.00466	CbGeAlD
Diclofenac—ABCB1—epithelium—pharynx cancer	0.00204	0.00464	CbGeAlD
Diclofenac—PLA2G2A—Metabolism—ADH7—pharynx cancer	0.00198	0.00353	CbGpPWpGaD
Diclofenac—PLA2G2A—Spinal Cord Injury—TP53—pharynx cancer	0.00196	0.00351	CbGpPWpGaD
Diclofenac—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00194	0.00347	CbGpPWpGaD
Diclofenac—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00193	0.00346	CbGpPWpGaD
Diclofenac—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00186	0.00333	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—B4GALT5—pharynx cancer	0.00185	0.00331	CbGpPWpGaD
Diclofenac—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00183	0.00327	CbGpPWpGaD
Diclofenac—ABCB1—trachea—pharynx cancer	0.00181	0.0041	CbGeAlD
Diclofenac—TTR—Extracellular matrix organization—CDH1—pharynx cancer	0.0018	0.00323	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—ADH1B—pharynx cancer	0.00173	0.0031	CbGpPWpGaD
Diclofenac—CXCL8—AP-1 transcription factor network—TP53—pharynx cancer	0.00172	0.00307	CbGpPWpGaD
Diclofenac—CXCL8—Spinal Cord Injury—CCND1—pharynx cancer	0.00172	0.00307	CbGpPWpGaD
Diclofenac—CYP1A1—lymph node—pharynx cancer	0.00171	0.00388	CbGeAlD
Diclofenac—TTR—Disease—B4GALT5—pharynx cancer	0.0017	0.00304	CbGpPWpGaD
Diclofenac—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.0017	0.00303	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—B4GALT5—pharynx cancer	0.00166	0.00296	CbGpPWpGaD
Diclofenac—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00165	0.00296	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CNDP2—pharynx cancer	0.0016	0.00287	CbGpPWpGaD
Diclofenac—ABCB1—lymphoid tissue—pharynx cancer	0.00157	0.00357	CbGeAlD
Diclofenac—CXCL8—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.00151	0.00271	CbGpPWpGaD
Diclofenac—PTGS1—lymph node—pharynx cancer	0.0015	0.00341	CbGeAlD
Diclofenac—ALOX5—Metabolism—ADH7—pharynx cancer	0.00145	0.00259	CbGpPWpGaD
Diclofenac—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00145	0.00259	CbGpPWpGaD
Diclofenac—PTGS2—lymph node—pharynx cancer	0.00144	0.00326	CbGeAlD
Diclofenac—ABCB1—spinal cord—pharynx cancer	0.00143	0.00324	CbGeAlD
Diclofenac—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00141	0.00252	CbGpPWpGaD
Diclofenac—CXCL8—Spinal Cord Injury—EGFR—pharynx cancer	0.00135	0.00241	CbGpPWpGaD
Diclofenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.00131	0.00234	CbGpPWpGaD
Diclofenac—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00128	0.00228	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—ADH1B—pharynx cancer	0.00127	0.00228	CbGpPWpGaD
Diclofenac—ABCB1—head—pharynx cancer	0.00127	0.00288	CbGeAlD
Diclofenac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00125	0.00224	CbGpPWpGaD
Diclofenac—CXCL8—Senescence and Autophagy in Cancer—TP53—pharynx cancer	0.00124	0.00222	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—B4GALT5—pharynx cancer	0.00122	0.00217	CbGpPWpGaD
Diclofenac—CXCL8—Spinal Cord Injury—TP53—pharynx cancer	0.00113	0.00202	CbGpPWpGaD
Diclofenac—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00112	0.002	CbGpPWpGaD
Diclofenac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00111	0.00199	CbGpPWpGaD
Diclofenac—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00111	0.00199	CbGpPWpGaD
Diclofenac—KCNQ3—Axon guidance—EGFR—pharynx cancer	0.0011	0.00197	CbGpPWpGaD
Diclofenac—KCNQ2—Axon guidance—EGFR—pharynx cancer	0.0011	0.00197	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CNDP2—pharynx cancer	0.00108	0.00193	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CNDP2—pharynx cancer	0.00105	0.00188	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—CCND1—pharynx cancer	0.000988	0.00177	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ADH7—pharynx cancer	0.000976	0.00175	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ADH7—pharynx cancer	0.00095	0.0017	CbGpPWpGaD
Diclofenac—ABCB1—lymph node—pharynx cancer	0.000889	0.00202	CbGeAlD
Diclofenac—CYP2C18—Metabolism—ADH1B—pharynx cancer	0.000856	0.00153	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CNDP2—pharynx cancer	0.000853	0.00153	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—EGFR—pharynx cancer	0.000833	0.00149	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ADH1B—pharynx cancer	0.000833	0.00149	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CNDP2—pharynx cancer	0.000823	0.00147	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—B4GALT5—pharynx cancer	0.000818	0.00146	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—B4GALT5—pharynx cancer	0.000796	0.00142	CbGpPWpGaD
Diclofenac—CXCL8—Cellular Senescence—TP53—pharynx cancer	0.000787	0.00141	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—EGFR—pharynx cancer	0.000784	0.0014	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—EGFR—pharynx cancer	0.000784	0.0014	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ADH7—pharynx cancer	0.000772	0.00138	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—CCND1—pharynx cancer	0.000753	0.00135	CbGpPWpGaD
Diclofenac—ABCC1—Disease—B4GALT5—pharynx cancer	0.000745	0.00133	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ADH7—pharynx cancer	0.000744	0.00133	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00071	0.00127	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00071	0.00127	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CNDP2—pharynx cancer	0.000696	0.00124	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ADH1B—pharynx cancer	0.000677	0.00121	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ADH1B—pharynx cancer	0.000653	0.00117	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—B4GALT5—pharynx cancer	0.000647	0.00116	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TP53—pharynx cancer	0.000639	0.00114	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ADH7—pharynx cancer	0.000629	0.00113	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—B4GALT5—pharynx cancer	0.000624	0.00112	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—EGFR—pharynx cancer	0.000594	0.00106	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—TP53—pharynx cancer	0.000594	0.00106	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—EGFR—pharynx cancer	0.000591	0.00106	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CNDP2—pharynx cancer	0.000552	0.000988	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ADH1B—pharynx cancer	0.000552	0.000986	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—EGFR—pharynx cancer	0.000535	0.000956	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.000531	0.000949	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—B4GALT5—pharynx cancer	0.000527	0.000943	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CNDP2—pharynx cancer	0.00052	0.00093	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000512	0.000916	CbGpPWpGaD
Diclofenac—PTGS2—Disease—B4GALT5—pharynx cancer	0.0005	0.000894	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ADH7—pharynx cancer	0.000499	0.000893	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TP53—pharynx cancer	0.000496	0.000887	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CNDP2—pharynx cancer	0.00049	0.000876	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ADH7—pharynx cancer	0.00048	0.000858	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ADH7—pharynx cancer	0.00047	0.000841	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000449	0.000804	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CNDP2—pharynx cancer	0.000447	0.000799	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ADH7—pharynx cancer	0.000443	0.000793	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ADH1B—pharynx cancer	0.000438	0.000783	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.000421	0.000753	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—B4GALT5—pharynx cancer	0.000419	0.000748	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ADH1B—pharynx cancer	0.000412	0.000737	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000406	0.000727	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ADH7—pharynx cancer	0.000404	0.000723	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CCND1—pharynx cancer	0.000403	0.00072	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.000402	0.000719	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000402	0.000718	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000401	0.000717	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—B4GALT5—pharynx cancer	0.000394	0.000705	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000392	0.0007	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ADH1B—pharynx cancer	0.000389	0.000695	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—B4GALT5—pharynx cancer	0.000371	0.000664	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.000366	0.000654	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000363	0.000649	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000363	0.000649	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000356	0.000637	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ADH1B—pharynx cancer	0.000354	0.000634	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ADH7—pharynx cancer	0.000354	0.000633	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000341	0.000609	CbGpPWpGaD
Diclofenac—ALB—Metabolism—B4GALT5—pharynx cancer	0.000339	0.000605	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000337	0.000603	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000331	0.000591	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000318	0.000569	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EGFR—pharynx cancer	0.000316	0.000565	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000313	0.000559	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ADH1B—pharynx cancer	0.00031	0.000555	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000304	0.000544	CbGpPWpGaD
Diclofenac—TTR—Disease—EGFR—pharynx cancer	0.000304	0.000543	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000297	0.000531	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.00029	0.000519	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000285	0.000509	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000283	0.000505	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000277	0.000496	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—pharynx cancer	0.000277	0.000495	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CCND1—pharynx cancer	0.000271	0.000485	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—pharynx cancer	0.000265	0.000474	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000248	0.000443	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EGFR—pharynx cancer	0.000241	0.000432	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000241	0.000431	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000239	0.000428	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000237	0.000424	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000218	0.00039	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EGFR—pharynx cancer	0.000213	0.00038	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000191	0.000342	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000183	0.000327	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCND1—pharynx cancer	0.000182	0.000325	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—pharynx cancer	0.000179	0.000319	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—pharynx cancer	0.000143	0.000255	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—pharynx cancer	0.000133	0.000238	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—pharynx cancer	0.000125	0.000224	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—pharynx cancer	0.00012	0.000214	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—pharynx cancer	8.92e-05	0.00016	CbGpPWpGaD
